Effect of interleukin-10 on the production of tumor necrosis factor-alpha by peripheral blood mononuclear cells from patients with chronic heart failure

American Journal of Cardiology

Volumn 90, Issue 4, 2002, Pages 384-389

  Bolger, Aidan P ^a   Sharma, Rakesh ^a   Von Haehling, Stephan ^a,c   Doehner, Wolfram ^a,c   Oliver, Brian ^a   Rauchhaus, Mathias ^a,b   Coats, Andrew J S ^a   Adcock, Ian M ^a   Anker, Stefan D ^a,c  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; LIPOPOLYSACCHARIDE; OXYGEN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD CELL; CELL ASSAY; CELL FREE SYSTEM; CELL ISOLATION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEALTH STATUS; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HUMAN CELL; IMMUNOLOGICAL PARAMETERS; INFLAMMATION; MONONUCLEAR CELL; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; SOLUBILITY; TREATMENT INDICATION; UNITED STATES;

AGED; ANALYSIS OF VARIANCE; CELLS, CULTURED; HEART FAILURE, CONGESTIVE; HUMANS; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MIDDLE AGED; REGRESSION ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037102274     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)02494-3     Document Type: Article

References (29)

1. Tumour necrosis factor in chronic heart failure: A peripheral view on pathogenesis, clinical manifestations and therapeutic implications
2. Plasma cytokine parameters and mortality in patients with chronic heart failure
3. Cytokines, and cytokine receptors in advanced heart failure. An analysis of the cytokine database from the Vesnarinone Trial (VEST)
4. Therapeutic implications of interleukin-10 in surgical disease
5. Interleukin-10: An anti-inflammatory cytokine with therapeutic potential
6. Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure
7. Induction of functional inducible nitric oxide synthase in monocytes of patients with congestive heart failure. Link with tumour necrosis factor-alpha
8. Recent insights into the role of tumor necrosis factor in the failing heart
9. Elevated soluble CD14 receptors and altered cytokines in chronic heart failure
10. Endotoxin and immune activation in chronic heart failure: A prospective cohort study
11. Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure
12. Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure
13. Clinical Trials Update. CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001
14. Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol: Results of a randomized study
15. Clinical, hematologic, and immunologic effects of interleukin-10 in humans
16. Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group
17. IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: A new therapeutic approach
18. Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: A pilot trial of interferon nonresponders
19. Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure
20. Monocyte activation in congestive heart failure due to coronary artery disease and idiopathic dilated cardiomyopathy
21. Elevated tumor necrosis factor alpha of blood mononuclear cells in patients with congestive heart failure
22. Cytokine generation capacities of monocytes are reduced in patients with severe heart failure
23. Lipopolysaccharide-dependent and lipopolysaccharide-independent pathways of monocyte desensitisation to lipopolysaccharides
24. Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action
25. Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: Selective expression of TLR3 in dendritic cells
26. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium
27. Interleukin-1 in myocardium and coronary arteries of patients with dilated cardiomyopathy
28. Elevated circulating levels of C-C chemokines in patients with congestive heart failure
29. Monocyte chemoattractant protein-1 enhances and interleukin-10 suppresses the production of inflammatory cytokines in adult rat cardiomyocytes